Related Experiment Video
Updated: Jul 5, 2026
A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
Huperzine A attenuates mitochondrial dysfunction after middle cerebral artery occlusion in rats
Chun Yan Zheng1, Hai Yan Zhang, Xi Can Tang
1State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People's Republic of China.
Abstract:
Mitochondrial dysfunction has been proved to contribute to ischemia-induced brain damage. In this study, which used a rat middle cerebral artery occlusion (MCAO) model, the protective effects of huperzine A (HupA) against mitochondrial dysfunction and brain damage were investigated. MCAO for 45 min followed by 4 hr of reperfusion significantly impaired the activities of mitochondrial respiratory chain enzymes (complex I, complex II-III, and complex IV) and alpha-ketoglutarate dehydrogenase, increased the production of reactive oxygen species (ROS), and induced mitochondrial swelling. Pretreatment of HupA at 0.1 mg/kg significantly preserved respiratory chain enzyme activities, decreased ROS production, and attenuated mitochondrial swelling. It could also significantly attenuate the neurological deficits (after 4 or 24 hr reperfusion) and reduce infarct volumes (after 24 hr reperfusion). Moreover, HupA protected isolated nonsynaptosomal mitochondria from calcium-induced damage in vitro by preserving mitochondrial membrane potential and decreasing ROS production. Overall, the present study indicates that HupA can ameliorate MCAO-induced mitochondrial dysfunction, and this might partially contribute to its protective effect on brain damage after 24 hr of reperfusion.
Insights
Huperzine A (HupA) protects the brain from stroke damage by preventing mitochondrial dysfunction. This study shows HupA reduces reactive oxygen species and preserves enzyme activity in MCAO rat models.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Mitochondrial dysfunction is a key factor in ischemia-induced brain damage.
- Huperzine A (HupA) is investigated for its potential neuroprotective properties.
Purpose of the Study:
- To investigate the protective effects of huperzine A (HupA) against mitochondrial dysfunction and brain damage in a rat middle cerebral artery occlusion (MCAO) model.
- To elucidate the mechanisms underlying HupA's neuroprotection.
Main Methods:
- A rat MCAO model was used to induce ischemia-reperfusion injury.
- Mitochondrial function, including respiratory chain enzyme activities and reactive oxygen species (ROS) production, was assessed.
- Neurological deficits and infarct volumes were evaluated after HupA pretreatment.
- In vitro experiments assessed HupA's protective effects on isolated mitochondria.
Main Results:
- MCAO impaired mitochondrial respiratory chain enzymes, increased ROS, and caused swelling.
- HupA pretreatment preserved enzyme activities, reduced ROS, and attenuated mitochondrial swelling.
- HupA significantly reduced neurological deficits and infarct volumes.
- In vitro, HupA protected mitochondria from calcium-induced damage, preserving membrane potential and decreasing ROS.
Conclusions:
- Huperzine A ameliorates MCAO-induced mitochondrial dysfunction.
- HupA's protective effects on brain damage may be partly due to its ability to mitigate mitochondrial dysfunction.
- HupA demonstrates significant neuroprotective potential against ischemic stroke.
